• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Johns Hopkins Tweaks Name of Health Insurance Plans To Reflect Large, Varied Roles

Article

In addition to a health plan for employees, Johns Hopkins Health Plans has a Medicare Advantage plan, a Medicaid managed care plan and a plan for the families of people who are on active duty in the U.S. military.

Many large health systems have health plans for their employees, so they have some experience as a payer/insurer as well as being a large provider. But a growing number of them are branching out from their employee-only health plans and fast becoming major players, at least at a regional level.

A prime example is Johns Hopkins and its famous hospital and medical school. Last week, Johns Hopkins HealthCare announced that it was changing its name to Johns Hopkins Health Plans. The namechanged entity has 470,000 members, of which only 55,000, or 11%, are Hopkins employees and their families.

In addition to the employee plan, the organization operates US Family Health Plan, a health insurance plan for active-duty family members and military retirees and their families that has a geographic reach that includes Maryland, Delaware, Washington, D.C., and parts of Pennsylvania, Virginia and West Virginia; Priority Partners, which it co-owns with the Maryland Community Health System, and which Hopkins says is Maryland’s largest Medicaid managed care plan; and Johns Hopkins Advantage MD, a Medicare Advantage plan.

Collectively, the plans generate more than $3 billion in premiums, according to the July 12 press release about the name tweak.

The press release about the name change says members won’t experience any change in benefits or network of provider. Enhanced scheduling functions and easier patient navigation will continue, the press release says.

“Our new name better captures our core business, which is helping our plan members access the top-tier healthcare and celebrated clinical and research assets of Johns Hopkins,” the press release quoted J.P. Holland, the CEO of Johns Hopkins Health Plans, as saying. Holland has been CEO for almost five years, according to this LinkedIn page.

According to Hopkins officials, the employee plan was formed in 1995. Priority Partners came under Johns Hopkins HealthCare a year later, followed by US Family Health Plan. The Medicare Advantage plan was added to the portfolio in 2016.

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.